Univariate survival analysis of patients with lung cancer
| Variable | Hazard ratio | 95% CI | p Value |
| Proportion of CD4+ PLY | 0.0004 | ||
| ⩽30% | 0.168 | 0.062 to 0.454 | |
| >30% | 1.000 | ||
| Proportion of CD8+ PLY | 0.0089 | ||
| ⩾35% | 0.198 | 0.059 to 0.677 | |
| <35% | 1.000 | ||
| p factor | 0.0015 | ||
| 0 | 0.173 | 0.063 to 0.47 | |
| 1 | 0.566 | 0.178 to 1.801 | |
| 2 | 1.297 | 0.332 to 5.068 | |
| 3 | 1.000 | ||
| Nodal status | 0.0036 | ||
| 0 | 0.92 | 0.18 to 0.464 | |
| 1 | 0.232 | 0.4 to 1.351 | |
| 2 | 0.418 | 0.088 to 1.981 | |
| 3 | 1.000 | ||
| Clinical stage | 0.0037 | ||
| IA | 0.076 | 0.021 to 0.266 | |
| IB | 0.335 | 0.085 to 1.319 | |
| IIA | 0.125 | 0.015 to 1.042 | |
| IIB | 0.459 | 0.132 to 1.594 | |
| IIIA | 0.408 | 0.128 to 1.296 | |
| IIIB | 1.000 | ||
| Histology | 0.859 | ||
| Squamous cell | 0.813 | 0.104 to 6.359 | |
| Adenocarcinoma | 1.023 | 0.133 to 7.836 | |
| Large cell | 1.000 | ||
PLY = pleural cavity.